Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Mast cell activation mediates blood–brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway

Open access

Abstract

Introduction: Sepsis-associated encephalopathy (SAE) is a diffuse cerebral dysfunction resulting from a systemic inflammatory response to infection; however, its pathophysiology remains unclear. Sepsis-induced neuroinflammation and blood–brain barrier (BBB) disruption are crucial factors in brain function disturbance in SAE. Mast cells (MCs) activation plays an important role in several neuroinflammation models; however, its role in SAE has not been comprehensively investigated. Methods: We first established a SAE model by cecal ligation puncture (CLP) surgery and checked the activation of MCs. MCs activation was checked using immumohistochemical staining and Toluidine Blue staining. We administrated cromolyn (10mg/ml), a MC stabilizer, to rescue the septic mice. Brain cytokines levels were measured using biochemical assays. BBB disruption was assessed by measuring levels of key tight-junction (TJ) proteins. Cognitive function of mice was analyzed by Y maze and open field test. Transwell cultures of brain microvascular endothelial cells (BMVECs) co-cultured with MCs were used to assess the interaction of BMVECs and MCs. Results: Results showed that MCs were overactivated in the hippocampus of CLP-induced SAE mice. Cromolyn intracerebroventricular (i.c.v) injection substantially inhibited the MCs activation and neuroinflammation responses, ameliorated BBB impairment, improved the survival rate and alleviated cognitive dysfunction in septic mice. In vitro experiments, we revealed that MCs activation increased the sensitivity of BMVECs against to lipopolysaccharide (LPS) challenge. Furthermore, we found that the histamine/histamine 1 receptor (H1R) mediated the interaction between MCs and BMVECs, and amplifies the LPS-induced inflammatory responses in BMVECs by modulating the TLR2/4-MAPK signaling pathway. Conclusions: MCs activation could mediate BBB impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2023.1090288

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sepsis-induced neuroinflammation, cognitive deficits and mast cells activation in brain tissues. (A) Schematic timeline of the experimental procedures. (B) The levels of TNF-α, IL-6, IL-1β and IL-10 in mice hippocampus tissues were detected by ELISA (n=6). Body weight (C) and survival rate (D) were observed in 7 days following surgery (body weight: n=6; survival rate: n=15). The total movement distance (E) and the time in the center zone (F) in the open field test, and the movement distance in zone C (G)) and the time in zone C (H) in the Y maze test were recorded to analyze the cognitive changes (n=6). (I) TB staining and tryptase IHC staining were used to detect activated MCs in the hippocampus CA1 region (400x, black arrow indicates MCs, n=6). (J) Quantification of TB and tryptase staining positive cells in the hippocampus CA1 region (n=6). (K) Levels of tryptase in the hippocampus CA1 region were detected by ELISA (n=6). MCs: Mast cells, CLP: Cecal Ligation and Puncture, SAE: Sepsis-associated encephalopathy, TB: Toluidine blue, IHC: immunohistochemistry. (ns: no significance, * p<0.05, ** p<0.01, *** p<0.001).
Figure 1 Sepsis-induced neuroinflammation, cognitive deficits and mast cells activation in brain tissues. (A) Schematic timeline of the experimental procedures. (B) The levels of TNF-α, IL-6, IL-1β and IL-10 in mice hippocampus tissues were detected by ELISA (n=6). Body weight (C) and survival rate (D) were observed in 7 days following surgery (body weight: n=6; survival rate: n=15). The total movement distance (E) and the time in the center zone (F) in the open field test, and the movement distance in zone C (G)) and the time in zone C (H) in the Y maze test were recorded to analyze the cognitive changes (n=6). (I) TB staining and tryptase IHC staining were used to detect activated MCs in the hippocampus CA1 region (400x, black arrow indicates MCs, n=6). (J) Quantification of TB and tryptase staining positive cells in the hippocampus CA1 region (n=6). (K) Levels of tryptase in the hippocampus CA1 region were detected by ELISA (n=6). MCs: Mast cells, CLP: Cecal Ligation and Puncture, SAE: Sepsis-associated encephalopathy, TB: Toluidine blue, IHC: immunohistochemistry. (ns: no significance, * p<0.05, ** p<0.01, *** p<0.001).CC BY · PubMed Central
Figure 2 Cromolyn defended neuroinflammation, improved SAE mice survive, and alleviated cognitive impairment. (A) Cromolyn inhibited MCs activation in the CA1 region of the hippocampus by TB staining and tryptase IHC staining (n=6). (B) Quantification of TB- and tryptase-positive cells (n=6). (C) ELISA test showed that cromolyn decreased the levels of TNF-α, IL-6, IL-1β and IL-10 in hippocampus tissue (n=6). (D) Cromolyn treatment improved 7-day survival rate in septic mice (n=15). The total movement distance (E) and the time in center (F) in the open field test, and the movement distance (G), and the time (H) in zone C in the Y maze test were increased after cromolyn treatment (n=6). MCs, Mast cell; CLP, Cecal Ligation and Puncture; SAE, Sepsis-associated encephalopathy; TB, Toluidine blue; IHC, immunohistochemistry; (ns, no significance, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).
Figure 2 Cromolyn defended neuroinflammation, improved SAE mice survive, and alleviated cognitive impairment. (A) Cromolyn inhibited MCs activation in the CA1 region of the hippocampus by TB staining and tryptase IHC staining (n=6). (B) Quantification of TB- and tryptase-positive cells (n=6). (C) ELISA test showed that cromolyn decreased the levels of TNF-α, IL-6, IL-1β and IL-10 in hippocampus tissue (n=6). (D) Cromolyn treatment improved 7-day survival rate in septic mice (n=15). The total movement distance (E) and the time in center (F) in the open field test, and the movement distance (G), and the time (H) in zone C in the Y maze test were increased after cromolyn treatment (n=6). MCs, Mast cell; CLP, Cecal Ligation and Puncture; SAE, Sepsis-associated encephalopathy; TB, Toluidine blue; IHC, immunohistochemistry; (ns, no significance, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).CC BY · PubMed Central
Figure 3 Cromolyn reduced BBB permeability in septic mice by inhibiting MC activation. (A) The brain water content was measured. Quantification of the Fluorescein sodium extravasation in the hippocampus (B) and the global brain tissue (C) Evans blue extravasation in the hippocampus (D) and the global brain of mice (E) was also detected (n=6). (F) The representative images of Evans blue staining of the brains (n=6). MCs, Mast cells; CLP, Cecal Ligation and Puncture; SAE, Sepsis-associated encephalopathy, BBB; Blood–brain barrier, (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).
Figure 3 Cromolyn reduced BBB permeability in septic mice by inhibiting MC activation. (A) The brain water content was measured. Quantification of the Fluorescein sodium extravasation in the hippocampus (B) and the global brain tissue (C) Evans blue extravasation in the hippocampus (D) and the global brain of mice (E) was also detected (n=6). (F) The representative images of Evans blue staining of the brains (n=6). MCs, Mast cells; CLP, Cecal Ligation and Puncture; SAE, Sepsis-associated encephalopathy, BBB; Blood–brain barrier, (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).CC BY · PubMed Central
Figure 4 The inhibition of MC activation by cromolyn protected BBB integrity in septic mice by alleviating TJ disruption. (A) Expression levels of MMP2/9 and TJ (ZO-1, occludin and claudin-5) proteins in the hippocampus were detected by Western blot (n=5). (B) Expression levels of MMP and TJ proteins were quantified and normalized to GAPDH levels (n=5). Expression levels of ZO-1 (C) and occludin (D) in the CA1 region of the hippocampus were analyzed by IF assay (400x, n=6). MCs, Mast cells; CLP, Cecal Ligation and Puncture; SAE, Sepsis-associated encephalopathy; BBB, Blood–brain barrier; TJs, Tight junctions; IF, immunofluorescence. (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).
Figure 4 The inhibition of MC activation by cromolyn protected BBB integrity in septic mice by alleviating TJ disruption. (A) Expression levels of MMP2/9 and TJ (ZO-1, occludin and claudin-5) proteins in the hippocampus were detected by Western blot (n=5). (B) Expression levels of MMP and TJ proteins were quantified and normalized to GAPDH levels (n=5). Expression levels of ZO-1 (C) and occludin (D) in the CA1 region of the hippocampus were analyzed by IF assay (400x, n=6). MCs, Mast cells; CLP, Cecal Ligation and Puncture; SAE, Sepsis-associated encephalopathy; BBB, Blood–brain barrier; TJs, Tight junctions; IF, immunofluorescence. (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).CC BY · PubMed Central
Figure 5 LPS successfully induced the degranulation of MCs, and cromolyn effectively stabilized LPS-induced MC activation in vitro. (A) Degranulation of P815 cells stimulated by LPS was analyzed by β-hexosaminidase release assay. C48/80 treatment was used as the positive control (n=3). (B) Morphological properties of MCs activation were investigated using the TB staining of the cell smears (Black arrow: activated MCs, red arrow ghost-like cell; 1000x; n=3). (C) Quantification of activated MCs in TB staining of the cell smears (n=3). ELISA was used to detect the levels of histamine (D), tryptase (E), TNF-α (F), IL-6 (G), IL-1β (H) and IL-10 (I) in the medium supernatant of P815 cells (n=3). LPS, Lipopolysaccharide; C48/80, Compound 48/80; TB, Toluidine blue. (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).
Figure 5 LPS successfully induced the degranulation of MCs, and cromolyn effectively stabilized LPS-induced MC activation in vitro. (A) Degranulation of P815 cells stimulated by LPS was analyzed by β-hexosaminidase release assay. C48/80 treatment was used as the positive control (n=3). (B) Morphological properties of MCs activation were investigated using the TB staining of the cell smears (Black arrow: activated MCs, red arrow ghost-like cell; 1000x; n=3). (C) Quantification of activated MCs in TB staining of the cell smears (n=3). ELISA was used to detect the levels of histamine (D), tryptase (E), TNF-α (F), IL-6 (G), IL-1β (H) and IL-10 (I) in the medium supernatant of P815 cells (n=3). LPS, Lipopolysaccharide; C48/80, Compound 48/80; TB, Toluidine blue. (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).CC BY · PubMed Central
Figure 6 Cromolyn treatment protected BMVEC functions from LPS-induced MCs activation. (A) Apoptotic BMVECs and Ki-67-positive cells were examined by Tunel staining and Ki-67 IF staining, respectively (400x, n=3). (B) Quantification of Tunel-positive and Ki-67-positive BMVECs (n=3). (C) Expression levels of MMP9/2 and TJ proteins (ZO-1, occludin and claudin-5) of bEnd.3 cells were analyzed by Western blot (n=3). (D) The expression of MMP and TJ proteins were quantified and normalized to GAPDH levels (n=3). (E) Expression levels of ZO-1 and occludin protein in bEnd.3 cells were examined by IF assay (800x, n=3). (F). Expression levels of ZO-1 and occludin were quantified in bEnd.3 cells in IF assay (n=3). LPS, Lipopolysaccharide, MCs, Mast cells; BMVECs, Brain microvascular endothelial cells; TJs, Tight junctions; IF, immunofluorescence. (ns, no significance, *p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).
Figure 6 Cromolyn treatment protected BMVEC functions from LPS-induced MCs activation. (A) Apoptotic BMVECs and Ki-67-positive cells were examined by Tunel staining and Ki-67 IF staining, respectively (400x, n=3). (B) Quantification of Tunel-positive and Ki-67-positive BMVECs (n=3). (C) Expression levels of MMP9/2 and TJ proteins (ZO-1, occludin and claudin-5) of bEnd.3 cells were analyzed by Western blot (n=3). (D) The expression of MMP and TJ proteins were quantified and normalized to GAPDH levels (n=3). (E) Expression levels of ZO-1 and occludin protein in bEnd.3 cells were examined by IF assay (800x, n=3). (F). Expression levels of ZO-1 and occludin were quantified in bEnd.3 cells in IF assay (n=3). LPS, Lipopolysaccharide, MCs, Mast cells; BMVECs, Brain microvascular endothelial cells; TJs, Tight junctions; IF, immunofluorescence. (ns, no significance, *p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).CC BY · PubMed Central
Figure 7 MC-secreted histamine amplified the LPS-induced inflammatory response in BMVECs through the H1R-TLR2/4-MAPK signaling pathway. (A) Expression levels of TLR2/4 and MAPK signaling pathway proteins (P38, P42/44 and JNK) in P815-bEnd.3 co-culture system were analyzed by Western blot (n=3). (B) Expression levels of TLR2/4 and MAPK signaling pathway proteins (P38, P42/44 and JNK) in the P815-bEnd.3 co-culture system were quantified and normalized to GAPDH levels (n=3). (C) Expression levels of H1R were checked by Western blot after bEnd.3 cells were over-expressed with H1R (n=3). (D) Expression levels of TLR2/4-MAPK signaling pathway proteins were checked by Western blot after bEnd.3 cells were over-expressed with H1R (n=3). (E) Expression levels of TLR2/4-MAPK signaling pathway proteins were quantified and normalized to GAPDH levels after bEnd.3 cells were over-expressed with H1R (n=3). (F) ELISA showed the changes of TNF-α, IL-6, IL-1β and IL-10 in medium supernatant after bEnd.3 cells were over-expressed with H1R (n=3). LPS, Lipopolysaccharide; MCs, Mast cells; H1R, histamine 1 receptor; TLR, Toll-like receptor; MAPK, Mitogen-activated protein kinases; (ns, no significance, *p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).
Figure 7 MC-secreted histamine amplified the LPS-induced inflammatory response in BMVECs through the H1R-TLR2/4-MAPK signaling pathway. (A) Expression levels of TLR2/4 and MAPK signaling pathway proteins (P38, P42/44 and JNK) in P815-bEnd.3 co-culture system were analyzed by Western blot (n=3). (B) Expression levels of TLR2/4 and MAPK signaling pathway proteins (P38, P42/44 and JNK) in the P815-bEnd.3 co-culture system were quantified and normalized to GAPDH levels (n=3). (C) Expression levels of H1R were checked by Western blot after bEnd.3 cells were over-expressed with H1R (n=3). (D) Expression levels of TLR2/4-MAPK signaling pathway proteins were checked by Western blot after bEnd.3 cells were over-expressed with H1R (n=3). (E) Expression levels of TLR2/4-MAPK signaling pathway proteins were quantified and normalized to GAPDH levels after bEnd.3 cells were over-expressed with H1R (n=3). (F) ELISA showed the changes of TNF-α, IL-6, IL-1β and IL-10 in medium supernatant after bEnd.3 cells were over-expressed with H1R (n=3). LPS, Lipopolysaccharide; MCs, Mast cells; H1R, histamine 1 receptor; TLR, Toll-like receptor; MAPK, Mitogen-activated protein kinases; (ns, no significance, *p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001).CC BY · PubMed Central
Figure 8 Interfering H1R expression in bEnd.3 cells decreased cell inflammation response. (A) Expression levels of TLR2/4-MAPK signaling pathway proteins were checked by Western blot after bEnd.3 cells were transfected with H1R siRNA (n=3). (B) Expression levels of TLR2/4-MAPK signaling pathway proteins were quantified and normalized to GAPDH levels after bEnd.3 cells were transfected with H1R siRNA (n=3). (C) Abundance of TNF-α, IL-6, IL-1β and IL-10 in medium supernatant was examined by ELISA after bEnd.3 cells were transfected with H1R siRNA (n=3). H1R: histamine 1 receptor, TLR: Toll-like receptor, MAPK: Mitogen-activated protein kinases. (ns, no significance, *p <0.05, ** p <0.01, *** p <0.001).
Figure 8 Interfering H1R expression in bEnd.3 cells decreased cell inflammation response. (A) Expression levels of TLR2/4-MAPK signaling pathway proteins were checked by Western blot after bEnd.3 cells were transfected with H1R siRNA (n=3). (B) Expression levels of TLR2/4-MAPK signaling pathway proteins were quantified and normalized to GAPDH levels after bEnd.3 cells were transfected with H1R siRNA (n=3). (C) Abundance of TNF-α, IL-6, IL-1β and IL-10 in medium supernatant was examined by ELISA after bEnd.3 cells were transfected with H1R siRNA (n=3). H1R: histamine 1 receptor, TLR: Toll-like receptor, MAPK: Mitogen-activated protein kinases. (ns, no significance, *p <0.05, ** p <0.01, *** p <0.001).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 46

Metadata

Authors
Yue, J., Tan, Y., Huan, R., Guo, J., Yang, S., Deng, M., Xiong, Y., Han, G., Liu, L., Liu, J., Cheng, Y., Zha, Y., & Zhang, J.
Affiliations
  • Second Affiliated Hospital of Chongqing Medical University (CN)
  • Guizhou Provincial People's Hospital (CN)
Corresponding author
  • Cheng, Yuan
  • Zha, Yan
  • Zhang, Jiqin
Venue
Frontiers in Immunology
Published
2023-02-01
Volume
14
Pages
1090288-1090288
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4320076980
Cited by
46
References
51
Citations by year
2026: 20 · 2025: 11 · 2024: 12 · 2023: 3
FWCI
4.72
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81960454, 81960344, 82260533)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Keywords
mast cell activation, sepsis-associated encephalopathy, blood-brain barrier disruption, cognitive impairment, histamine, histamine H1 receptor, neuroinflammation, disodium cromoglycate, brain microvascular endothelial cells, lipopolysaccharide, tight junction proteins, hippocampus, cecal ligation and puncture
MeSH terms
Neuroinflammatory Diseases, Animals, Blood-Brain Barrier, Cromolyn Sodium, Histamine, Lipopolysaccharides, Mast Cells, Sepsis, Endothelial Cells, Mice, Cognitive Dysfunction, Tight Junction Proteins, Sepsis-Associated Encephalopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mast cell activation mediates blood–brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway. https://app.cochat.ai/papers/10.3389/fimmu.2023.1090288
The paper
Yue, J., Tan, Y., Huan, R., Guo, J., Yang, S., Deng, M., Xiong, Y., Han, G., Liu, L., Liu, J., Cheng, Y., Zha, Y., & Zhang, J. (2023). Mast cell activation mediates blood–brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1090288

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.